Core Laboratories NV reports results for the quarter ended in March - Earnings Summary

Core Laboratories

27/04/2023 24:21

* Core Laboratories NV  CLB.N  reported quarterly adjusted
earnings of 19 cents​​ per share for the quarter ended in March.
The mean expectation of eight analysts for the quarter was
for earnings of 16 cents per share.
    * Revenue rose 11.3% to $128.36 million from a year ago;
analysts
expected $125.93 million. 
    * Core Laboratories NV's reported EPS for the quarter was 5
cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.5%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates 
    * Core Laboratories NV shares had fallen by 4.4% this
quarter and
gained 4.0% so far this year.
    * The company reported quarterly net income of $2.37
million.
    * Wall Street's median 12-month price target for Core
Laboratories
NV is $21.75 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 26 at 11:21 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.16           0.19           Beat
 Dec. 31 2022      0.20           0.20           Met
 Sep. 30 2022      0.15           0.18           Beat
 Jun. 30 2022      0.14           0.12           Missed